Annual ROE
256.97%
+793.53%+147.89%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual return on equity is 256.97%, with the most recent change of +793.53% (+147.89%) on December 31, 2023.
- During the last 3 years, NRXP annual ROE has risen by +138.68% (+117.24%).
- NRXP annual ROE is now at all-time high.
Performance
NRXP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
127.35%
-65.76%-34.05%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly return on equity is 127.35%, with the most recent change of -65.76% (-34.05%) on September 30, 2024.
- Over the past year, NRXP quarterly ROE has dropped by -158.90% (-55.51%).
- NRXP quarterly ROE is now -98.32% below its all-time high of 7591.37%, reached on September 30, 2023.
Performance
NRXP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NRXP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +147.9% | -55.5% |
| 3 y3 years | +117.2% | +150.3% |
| 5 y5 years | +117.2% | - |
NRXP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +147.9% | -98.3% | +105.6% |
| 5 y | 5-year | at high | +147.9% | -98.3% | +105.6% |
| alltime | all time | at high | +147.9% | -98.3% | +105.6% |
NRx Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 127.35%(-34.1%) |
| Jun 2024 | - | 193.11%(-32.5%) |
| Mar 2024 | - | 286.25%(-50.1%) |
| Dec 2023 | 256.97%(-147.9%) | 573.14%(-92.5%) |
| Sep 2023 | - | 7591.37%(-1124.6%) |
| Jun 2023 | - | -740.89%(+144.3%) |
| Mar 2023 | - | -303.25%(+54.9%) |
| Dec 2022 | -536.56% | -195.76%(-22.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -253.28%(-37.5%) |
| Jun 2022 | - | -404.94%(-45.0%) |
| Mar 2022 | - | -736.14%(-67.5%) |
| Dec 2021 | -447.29%(-478.1%) | -2263.19%(-465.6%) |
| Sep 2021 | - | 618.96%(+149.6%) |
| Jun 2021 | - | 247.99%(+43.4%) |
| Mar 2021 | - | 172.89%(+50.8%) |
| Dec 2020 | 118.29% | 114.66% |
FAQ
- What is NRx Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual ROE year-on-year change?
- What is NRx Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly ROE year-on-year change?
What is NRx Pharmaceuticals annual return on equity?
The current annual ROE of NRXP is 256.97%
What is the all time high annual ROE for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual return on equity is 256.97%
What is NRx Pharmaceuticals annual ROE year-on-year change?
Over the past year, NRXP annual return on equity has changed by +793.53% (+147.89%)
What is NRx Pharmaceuticals quarterly return on equity?
The current quarterly ROE of NRXP is 127.35%
What is the all time high quarterly ROE for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly return on equity is 7591.37%
What is NRx Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, NRXP quarterly return on equity has changed by -158.90% (-55.51%)